Enhanced expression of the beta II subspecies of protein kinase C in differentiating erythroleukemia cells.
Polyclonal antipeptide antibodies which recognize selected isozymes (alpha, beta I, beta II, and gamma) of the protein kinase C family were used to identify specific subspecies in undifferentiated Friend erythroleukemia cells and in cells triggered to differentiate with hexamethylene bisacetamide. The beta II isozyme of protein kinase C was the primary isozyme expressed and its abundance was significantly increased (P less than 0.05) in differentiated cells. Differences in immunostaining between control and experimental groups were objectively quantitated by determining percentage transmission of light through cells based on color threshold rather than gray intensity levels. Staining was localized to the cytoplasm predominantly in differentiated cells, whereas nuclei stained more intensely in undifferentiated cells. These results provide immunocytochemical evidence to support the hypothesis that changes in the expression of the beta II subspecies of protein kinase C are essential to the programmed maturation of differentiating Friend erythroleukemia cells.
Beckman
B S
BS
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112.
Mason-Garcia
M
M
Martinez
M I
MI
Fermin
C
C
D000818:Animals; D002454:Cell Differentiation; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D002471:Cell Transformation, Neoplastic / Q000378:metabolism / Q000473:pathology*; D015870:Gene Expression / Q000235:genetics / Q000502:physiology; D007150:Immunohistochemistry; D007527:Isoenzymes / Q000235:genetics; D004915:Leukemia, Erythroblastic, Acute / Q000201:enzymology / Q000473:pathology* / Q000503:physiopathology; D007942:Leukemia, Experimental / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D051379:Mice; D011493:Protein Kinase C / Q000235:genetics* / Q000378:metabolism
D007527:Isoenzymes; D011493:Protein Kinase C